Hanna Taipaleenmäki

20PUBLICATIONS
52CO-AUTHORS
Molecular targetsHaematologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 04, 2026
One axis, two skeletal fates - PD-L1 blockade spares bone where PD-1 blockade does not. Editorial on Searcy et al. "Programmed cell death ligand 1 (PD-L1) inhibition in tumor-naïve mice is bone-sparing throughout the lifespan".

|Jun 16, 2026
Complement factor H (CFH), an immune factor enhances osteoblast differentiation and correlates with bone density.

|Jun 11, 2026
Bone-derived Osterix+ osteolineage cells are a source of tumor-promoting myofibroblastic cancer-associated fibroblasts in breast cancer.

|May 14, 2026
The endosteal niche regulates breast cancer cell dormancy in bone: identification of new molecular determinants.

|Dec 15, 2025
Therapeutic Management of Glucocorticoid-Induced Osteoporosis with a Focus on Older Adults: A Narrative Review.

Elena Tsourdi, Ulrike Baschant, Martina Rauner

|Aug 14, 2025
Tgif1-deficiency impairs osteoclast differentiation through PP2A-mediated ERK1/2 dephosphorylation and attenuates bone loss in mice.

Miki Maeda, Hiroaki Saito, Amy B P Ribet

Pageof 4

Frequent Collaborators

4 joint publications

Eric Hesse

3 joint publications

Daniel J Smit

2 joint publications

Christina Møller Andreasen

2 joint publications

Martina Rauner